IC
SRDX

Innealta Capital’s Surmodics SRDX Stock Holding History

Innealta Capital’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18
Closed -$757 – 1465
2024
Q2 		$757 Buy
+18
New +$614 ﹤0.01% 1371

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Innealta Capital's SRDX Position: Q3 2024 in Review

Innealta Capital sold out of Surmodics (SRDX) in Q3 2024, closing a stake of 18 shares — an estimated $757 sold.

Innealta Capital first reported a position in SRDX in Q2 2024 and held it in 1 quarter. The position peaked at $757 in Q2 2024. 126 funds tracked by Wall St. Rank hold SRDX as of Q3 2024.

  • Innealta Capital reported no remaining Surmodics position as of Q3 2024 after selling out during the quarter.
  • Innealta Capital sold 18 Surmodics shares in Q3 2024, an estimated $757.
  • Innealta Capital first reported a position in Surmodics in Q2 2024 and held it in 1 quarter.
  • Innealta Capital's Surmodics position peaked at $757 in Q2 2024.
  • 126 funds tracked by Wall St. Rank held Surmodics as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.